Hydroxychloroquine: Immune Modulation for Chronic Conditions
| Product dosage: 200mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $5.01 | $50.11 (0%) | 🛒 Add to cart |
| 20 | $4.01 | $100.23 $80.18 (20%) | 🛒 Add to cart |
| 30 | $3.67 | $150.34 $110.25 (27%) | 🛒 Add to cart |
| 60 | $3.51 | $300.68 $210.48 (30%) | 🛒 Add to cart |
| 90 | $3.34 | $451.02 $300.68 (33%) | 🛒 Add to cart |
| 120 | $2.92 | $601.36 $350.79 (42%) | 🛒 Add to cart |
| 180 | $2.78 | $902.04 $501.14 (44%) | 🛒 Add to cart |
| 270 | $2.60 | $1353.06 $701.59 (48%) | 🛒 Add to cart |
| 360 | $2.39
Best per pill | $1804.09 $861.95 (52%) | 🛒 Add to cart |
| Product dosage: 400mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $7.02 | $70.16 (0%) | 🛒 Add to cart |
| 20 | $6.01 | $140.32 $120.27 (14%) | 🛒 Add to cart |
| 30 | $5.68 | $210.48 $170.39 (19%) | 🛒 Add to cart |
| 60 | $5.35 | $420.95 $320.73 (24%) | 🛒 Add to cart |
| 90 | $5.01 | $631.43 $451.02 (29%) | 🛒 Add to cart |
| 120 | $4.59 | $841.91 $551.25 (35%) | 🛒 Add to cart |
| 180 | $4.45 | $1262.86 $801.82 (37%) | 🛒 Add to cart |
| 270 | $4.27 | $1894.29 $1152.61 (39%) | 🛒 Add to cart |
| 360 | $4.04
Best per pill | $2525.72 $1453.29 (42%) | 🛒 Add to cart |
Synonyms | |||
Hydroxychloroquine is an oral disease-modifying antirheumatic drug (DMARD) with immunomodulatory properties, primarily indicated for autoimmune disorders and malaria prophylaxis. As a 4-aminoquinoline derivative, it alters lysosomal pH and autoantigen processing, thereby inhibiting Toll-like receptor signaling and cytokine production. Its well-established safety profile and dual mechanism—combining anti-inflammatory and antimalarial actions—make it a cornerstone in long-term management protocols. Clinical evidence supports its efficacy in reducing disease activity and preventing flares across multiple indications.
Features
- Chemical class: 4-Aminoquinoline compound
- Available formulations: 200mg and 400mg oral tablets
- Mechanism: Lysosomal alkalinization, inhibition of antigen presentation, and cytokine suppression
- Half-life: Approximately 40 days due to extensive tissue binding
- Metabolism: Hepatic via CYP2D6, CYP3A4, and CYP2C8
- Excretion: Renal (50%) and fecal (25%)
- Pregnancy category: FDA Category C (requires risk-benefit assessment)
Benefits
- Reduces systemic inflammation in autoimmune conditions by modulating immune cell activity
- Decreases frequency and severity of disease flares in lupus and rheumatoid arthritis
- Provides chemoprophylaxis against malaria in endemic regions
- May improve lipid profiles and reduce thrombotic risk in certain patient populations
- Delays radiographic progression in inflammatory arthritis
- Offers once-daily dosing convenience for improved adherence
Common use
Hydroxychloroquine is FDA-approved for treatment of uncomplicated malaria, chronic discoid lupus erythematosus, systemic lupus erythematosus, and rheumatoid arthritis. Off-label uses include Sjögren’s syndrome, porphyria cutanea tarda, and Q fever. In rheumatology, it’s often combined with other DMARDs like methotrexate. For malaria prophylaxis, it’s indicated for travelers to chloroquine-sensitive areas.
Dosage and direction
Rheumatoid arthritis: Initial dose 400-600mg daily, reducing to 200-400mg daily after response. Lupus: 200-400mg daily. Malaria prophylaxis: 400mg weekly starting 1-2 weeks before travel and continuing for 4 weeks after return. Take with food or milk to minimize GI upset. Regular ophthalmologic screening is mandatory due to retinal toxicity risk.
Precautions
Regular ophthalmologic examinations (including visual fields, SD-OCT, and fundoscopy) every 6-12 months are essential. Monitor for muscle weakness, hematologic changes, and hepatic enzymes. Use caution in patients with G6PD deficiency, psoriasis, or hepatic impairment. May exacerbate porphyria. Educate patients about sun protection due to photosensitivity risk.
Contraindications
Known hypersensitivity to 4-aminoquinoline compounds. Pre-existing retinal field changes attributable to antimalarials. Concurrent use with other drugs known to cause retinal toxicity. Not recommended in children under 6 years except for malaria treatment.
Possible side effect
Common: Nausea, diarrhea, abdominal cramps, headache, dizziness. Less common: Retinopathy, corneal deposits, bleaching of hair, skin eruptions. Rare: Cardiomyopathy, neuromyopathy, blood dyscrasias, severe hypoglycemia. Retinal toxicity is irreversible and dose-related (>5mg/kg real weight daily increases risk).
Drug interaction
Significant interactions with digoxin (increased levels), insulin/oral hypoglycemics (enhanced effect), cyclosporine (increased levels), and antiepileptics (lowered seizure threshold). May potentiate QT-prolonging agents. Avoid concomitant methoquine due to seizure risk. CYP2D6 inhibitors may increase hydroxychloroquine concentrations.
Missed dose
If forgotten, take as soon as remembered unless close to next dose. Do not double dose. For weekly malaria prophylaxis: Take immediately and resume weekly schedule. Maintain consistent timing to ensure therapeutic levels.
Overdose
Symptoms include headache, visual disturbances, cardiovascular collapse, seizures, and hypokalemia. Management is supportive: gastric lavage if recent ingestion, activated charcoal, respiratory and cardiac support. ECG monitoring essential due to QT prolongation risk. Death can occur within hours with doses >4g in adults.
Storage
Store at 20-25°C (68-77°F) in original container. Protect from light and moisture. Keep tightly closed and away from children. Do not use if tablets show discoloration or deterioration.
Disclaimer
This information does not replace professional medical advice. Dosage must be individualized based on clinical condition, renal function, and actual body weight. Retinal toxicity risk requires ongoing specialist supervision. Not all indications are approved in all countries. Prescription required.
Reviews
“Hydroxychloroquine remains fundamental in our lupus management protocols. Its steroid-sparing effect and favorable safety profile make it invaluable for long-term control.” - Rheumatology Specialist, 15 years experience
“While requiring vigilant monitoring, hydroxychloroquine’s dual anti-inflammatory and immunomodulatory actions provide unique benefits that newer biologics often cannot replace.” - Clinical Immunologist
“Malaria prophylaxis compliance improves significantly with weekly dosing compared to daily regimens. However, geographic resistance patterns must guide prescribing.” - Tropical Medicine Specialist